Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical pentoxifylline for diabetic foot ulcers
IRCT20260620069881N1Phase 3Recruiting
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Pentoxifylline cream with Placebo cream (2 arms). Primary endpoints: Reduction in wound area, Reduction in wound depth and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20260620069881N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260620069881N1.